+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments), Technology (PCR, INAAT), Application (Oncology, Genetic Testing), Test Location, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 270 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 4764587
Description Jump to:
The global molecular diagnostics market is expected to reach USD 17.97 billion by 2030, and expanding at a CAGR of 4.5% from 2024 to 2030. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth.

Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.

Companies are expanding their product portfolios with the acquisition of smaller companies. For instance, in March 2021, Hologic announced the acquisition of Diagenode-a molecular diagnostic company with a wide range of PCR instruments, facilitating the detection of over 30 bacteria-for USD 159 million. Similarly, in April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. at a price of USD 24.05 per share in cash, and it holds around 82.89% of total shares of GenMark Diagnostics. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, which can be utilized in developing tests for infectious diseases, including bloodstream infections.

Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the global molecular diagnostics market.

Molecular Diagnostics Market Report Highlights

  • The reagents segment dominated the market and accounted for a share of 62.2% of the global revenue in 2023. It is expected to maintain its dominance throughout the forecast years owing to its wide application scope in research & clinical settings and increasing adoption of novel tests.
  • The polymerase chain reaction technology segment accounted for the largest revenue share in 2023. This is attributed to its use in detecting COVID-19 and other infectious diseases.
  • The infectious diseases segment accounted for the largest revenue share in 2023. The increased usage of molecular, particularly PCR tests, for diagnosing COVID-19 has increased the segment share significantly.
  • The central laboratories segment dominated the industry in 2023 owing to high procedure volumes for COVID testing and other healthcare indications in central laboratories.
  • North America dominated the market and accounted for a 39.3% share in 2023. This is attributed to the rising epidemiology of infectious as well as chronic diseases, thus, encouraging companies to introduce novel molecular diagnostic tests, thereby boosting market growth.
  • Asia-Pacific is anticipated to exhibit significant growth from 2024 to 2030 owing to increased market penetration, initiatives of local market players to increase the adoption of novel diagnostic technologies, and high unmet market needs.


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.7. Details of Primary Research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Molecular Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increase in geriatric population
3.2.1.2. Introduction of technologically advanced products
3.2.1.3. Increase in demand for point-of-care Testing
3.2.1.4. Growing prevalence of target diseases
3.2.1.5. Increasing external funding for R&D
3.2.2. Market Restraints Analysis
3.2.2.1. Presence of ambiguous regulatory framework
3.2.2.2. High prices of molecular diagnostics tests
3.3. Molecular Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.4. Market Opportunity Analysis
3.5. CLIA-Waived Tests and Instruments
3.6. Pricing Analysis
Chapter 4. Molecular Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Molecular Diagnostics Market: Product Movement Analysis, USD Million, 2023 & 2030 (Volume Analysis)
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold)
4.4. Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Tests Sold)
4.5. Software
4.5.1. Software Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Molecular Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Technology Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Molecular Diagnostics Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Polymerase chain reaction (PCR)
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. PCR, by Type
5.4.1.2.1. Multiplex PCR
5.4.1.2.1.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.1.2.2. Other PCR
5.4.1.2.2.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.1.3. PCR, by Product
5.4.1.3.1. Instruments
5.4.1.3.1.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Instruments Sold)
5.4.1.3.2. Reagents
5.4.1.3.2.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million) (Volume, Number of Tests Sold)
5.4.1.3.3. Others
5.4.1.3.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2. In Situ Hybridization (ISH)
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Instruments
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Instruments Sold)
5.4.2.3. Reagents
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Tests Sold)
5.4.2.4. Others
5.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3.2. Instruments
5.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Instruments Sold)
5.4.3.3. Reagents
5.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Tests Sold)
5.4.3.4. Others
5.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Chips and Microarrays
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4.2. Instruments
5.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Instruments Sold)
5.4.4.3. Reagents
5.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Tests Sold)
5.4.4.4. Others
5.4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Mass Spectrometry
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5.2. Instruments
5.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Instruments Sold)
5.4.5.3. Reagents
5.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Tests Sold)
5.4.5.4. Others
5.4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Sequencing
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6.2. Instruments
5.4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Instruments Sold)
5.4.6.3. Reagents
5.4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Tests Sold)
5.4.6.4. Others
5.4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.7. Transcription Mediated Amplification (TMA)
5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.7.2. Instruments
5.4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Instruments Sold)
5.4.7.3. Reagents
5.4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Tests Sold)
5.4.7.4. Others
5.4.7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.8. Others
5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.8.2. Instruments
5.4.8.2.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Instruments Sold)
5.4.8.3. Reagents
5.4.8.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Volume, Number of Tests Sold)
5.4.8.4. Services
5.4.8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Molecular Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Molecular Diagnostics Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Oncology
6.3.1. Oncology Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.2. Breast Cancer
6.3.2.1. Breast Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.3. Prostate Cancer
6.3.3.1. Prostate Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.4. Colorectal Cancer
6.3.4.1. Colorectal Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.5. Cervical Cancer
6.3.5.1. Cervical Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.6. Kidney Cancer
6.3.6.1. Kidney Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.7. Liver Cancer
6.3.7.1. Liver Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.8. Blood Cancer
6.3.8.1. Blood Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.9. Lung Cancer
6.3.9.1. Lung Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.3.10. Other Cancer
6.3.10.1. Other Cancer Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Pharmacogenomics
6.4.1. Pharmacogenomics Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Infectious Diseases
6.5.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
6.5.2.1. Methicillin-resistant Staphylococcus Aureus (MRSA) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.3. Clostridium Difficile
6.5.3.1. Clostridium Difficile Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.4. Vancomycin-resistant Enterococci (VRE)
6.5.4.1. Vancomycin-resistant Enterococci (VRE) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.5. Carbapenem-resistant Bacteria
6.5.5.1. Carbapenem-resistant Bacteria Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.6. Flu
6.5.6.1. Flu Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.7. Respiratory Syncytial Virus (RSV)
6.5.7.1. Respiratory Syncytial Virus (RSV) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.8. Candida
6.5.8.1. Candida Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.9. Tuberculosis and Drug-resistant TBA
6.5.9.1. Tuberculosis and Drug-resistant TBA Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.10. Meningitis
6.5.10.1. Meningitis Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.11. Gastrointestinal Panel Testing
6.5.11.1. Gastrointestinal Panel Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.12. Chlamydia
6.5.12.1. Chlamydia Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.13. Gonorrhea
6.5.13.1. Gonorrhea Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.14. HIV
6.5.14.1. HIV Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.15. Hepatitis C
6.5.15.1. Hepatitis C Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.16. Hepatitis B
6.5.16.1. Hepatitis B Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5.17. Other Infectious Disease
6.5.17.1. Other Infectious Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Genetic Testing
6.6.1. Genetic Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6.2. Newborn Screening
6.6.2.1. Newborn Screening Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6.3. Predictive and Presymptomatic Testing
6.6.3.1. Predictive and Presymptomatic Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6.4. Other Genetic Testing
6.6.4.1. Other Genetic Testing Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Neurological Disease
6.7.1. Neurological Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Cardiovascular Disease
6.8.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.9. Microbiology
6.9.1. Microbiology Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Molecular Diagnostics Market: Test Location Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Molecular Diagnostics Market: Test Location Movement Analysis, USD Million, 2023 & 2030
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Central Laboratories
7.4.1. Central Laboratories Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Self-Test or OTC
7.5.1. Self-Test or OTC Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
List of Tables
Table 1 Country share estimation
Table 2 North America molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 3 North America molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 4 North America molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 5 North America PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 6 North America PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 7 North America ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 8 North America INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 9 North America chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 10 North America mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 11 North America sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 12 North America TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 13 North America others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 14 North America molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 15 North America molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 16 North America molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 17 North America molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 18 U.S. molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 19 U.S. molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 20 U.S. molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 21 U.S. PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 22 U.S. PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 23 U.S. ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 24 U.S. INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 25 U.S. chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 26 U.S. mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 27 U.S. sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 28 U.S. TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 29 U.S. others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 30 U.S. molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 31 U.S. molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 32 U.S. molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 33 U.S. molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 34 Canada molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 35 Canada molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 36 Canada molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 37 Canada PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 38 Canada PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 39 Canada ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 40 Canada INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 41 Canada chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 42 Canada mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 43 Canada sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 44 Canada TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 45 Canada others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 46 Canada molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 47 Canada molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 48 Canada molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 49 Canada molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 50 Europe molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 51 Europe molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 52 Europe molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 53 Europe PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 54 Europe PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 55 Europe ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 56 Europe INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 57 Europe chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 58 Europe mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 59 Europe sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 60 Europe TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 61 Europe others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 62 Europe molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 63 Europe molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 64 Europe molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 65 Europe molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 66 UK molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 67 UK molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 68 UK molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 69 UK PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 70 UK PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 71 UK ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 72 UK INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 73 UK chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 74 UK mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 75 UK sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 76 UK TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 77 UK others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 78 UK molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 79 UK molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 80 UK molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 81 UK molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 82 Germany molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 83 Germany molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 84 Germany molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 85 Germany PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 86 Germany PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 87 Germany ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 88 Germany INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 89 Germany chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 90 Germany mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 91 Germany sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 92 Germany TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 93 Germany others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 94 Germany molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 95 Germany molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 96 Germany molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 97 Germany molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 98 France molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 99 France molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 100 France molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 101 France PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 102 France PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 103 France ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 104 France INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 105 France chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 106 France mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 107 France sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 108 France TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 109 France others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 110 France molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 111 France molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 112 France molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 113 France molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 114 Spain molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 115 Spain molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 116 Spain molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 117 Spain PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 118 Spain PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 119 Spain ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 120 Spain INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 121 Spain chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 122 Spain mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 123 Spain sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 124 Spain TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 125 Spain others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 126 Spain molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 127 Spain molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 128 Spain molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 129 Spain molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 130 Italy molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 131 Italy molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 132 Italy molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 133 Italy PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 134 Italy PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 135 Italy ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 136 Italy INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 137 Italy chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 138 Italy mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 139 Italy sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 140 Italy TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 141 Italy others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 142 Italy molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 143 Italy molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 144 Italy molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 145 Italy molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 146 Belgium molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 147 Belgium molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 148 Belgium molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 149 Belgium PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 150 Belgium PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 151 Belgium ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 152 Belgium INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 153 Belgium chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 154 Belgium mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 155 Belgium sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 156 Belgium TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 157 Belgium others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 158 Belgium molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 159 Belgium molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 160 Belgium molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 161 Belgium molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 162 Switzerland molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 163 Switzerland molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 164 Switzerland molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 165 Switzerland PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 166 Switzerland PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 167 Switzerland ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 168 Switzerland INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 169 Switzerland chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 170 Switzerland mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 171 Switzerland sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 172 Switzerland TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 173 Switzerland others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 174 Switzerland molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 175 Switzerland molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 176 Switzerland molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 177 Switzerland molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 178 Netherlands molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 179 Netherlands molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 180 Netherlands molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 181 Netherlands PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 182 Netherlands PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 183 Netherlands ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 184 Netherlands INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 185 Netherlands chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 186 Netherlands mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 187 Netherlands sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 188 Netherlands TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 189 Netherlands others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 190 Netherlands molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 191 Netherlands molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 192 Netherlands molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 193 Netherlands molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 194 Poland molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 195 Poland molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 196 Poland molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 197 Poland PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 198 Poland PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 199 Poland ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 200 Poland INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 201 Poland chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 202 Poland mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 203 Poland sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 204 Poland TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 205 Poland others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 206 Poland molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 207 Poland molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 208 Poland molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 209 Poland molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 210 Austria molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 211 Austria molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 212 Austria molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 213 Austria PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 214 Austria PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 215 Austria ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 216 Austria INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 217 Austria chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 218 Austria mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 219 Austria sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 220 Austria TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 221 Austria others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 222 Austria molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 223 Austria molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 224 Austria molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 225 Austria molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 226 Denmark molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 227 Denmark molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 228 Denmark molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 229 Denmark PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 230 Denmark PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 231 Denmark ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 232 Denmark INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 233 Denmark chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 234 Denmark mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 235 Denmark sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 236 Denmark TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 237 Denmark others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 238 Denmark molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 239 Denmark molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 240 Denmark molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 241 Denmark molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 242 Sweden molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 243 Sweden molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 244 Sweden molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 245 Sweden PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 246 Sweden PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 247 Sweden ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 248 Sweden INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 249 Sweden chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 250 Sweden mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 251 Sweden sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 252 Sweden TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 253 Sweden others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 254 Sweden molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 255 Sweden molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 256 Sweden molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
Table 257 Sweden molecular diagnostics market estimates and forecasts, by genetic testing, 2018-2030 (USD Million)
Table 258 Turkey molecular diagnostics market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 259 Turkey molecular diagnostics market estimates and forecasts, by test location, 2018-2030 (USD Million)
Table 260 Turkey molecular diagnostics market estimates and forecasts, by technology, 2018-2030 (USD Million)
Table 261 Turkey PCR market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 262 Turkey PCR market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 263 Turkey ISH market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 264 Turkey INAAT market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 265 Turkey chips and microarrays market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 266 Turkey mass spectrometry market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 267 Turkey sequencing market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 268 Turkey TMA market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 269 Turkey others technology market estimates and forecasts, by product, 2018-2030 (USD Million)
Table 270 Turkey molecular diagnostics market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 271 Turkey molecular diagnostics market estimates and forecasts, by oncology, 2018-2030 (USD Million)
Table 272 Turkey molecular diagnostics market estimates and forecasts, by infectious diseases, 2018-2030 (USD Million)
List of Figures
Fig. 1 Molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Molecular diagnostics market snapshot
Fig. 10 Parent market outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Global population by age group, 2017, 2021, & 2030
Fig. 14 General trend shifts from laboratory to point-of-care
Fig. 15 Market restrain relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (Political & legal, economic and technological)
Fig. 18 Strategy mapping
Fig. 19 Competition categorization
Fig. 20 Company market share analysis - Molecular diagnostics market, 2023
Fig. 21 Company market share analysis - Molecular diagnostics, oncology, 2023
Fig. 22 Company market share analysis - Molecular diagnostics, pharmacogenomics, 2023
Fig. 23 Company market share analysis - Molecular diagnostics, infectious diseases, 2023
Fig. 24 Company market share analysis - Molecular diagnostics, genetic testing, 2023
Fig. 25 Company market share analysis - Molecular diagnostics, others (neurological disease, cardiovascular diseases, microbiology, others), 2023
Fig. 26 Company market share analysis - Molecular diagnostics, polymerase chain reaction, 2023
Fig. 27 Company market share analysis - Molecular diagnostics, in situ hybridization, 2023
Fig. 28 Company market share analysis - Molecular diagnostics, INAAT, 2023
Fig. 29 Company market share analysis - Molecular diagnostics, chips & microarrays, 2023
Fig. 30 Company market share analysis - Molecular diagnostics, mass spectrometry, 2023
Fig. 31 Company market share analysis - Molecular diagnostics, sequencing, 2023
Fig. 32 Company market share analysis - Molecular diagnostics, transcription mediated amplification, 2023
Fig. 33 Company market share analysis - Molecular diagnostics, oncology, 2023
Fig. 34 Company market position analysis
Fig. 35 Company market position analysis
Fig. 36 Competitive dashboard analysis
Fig. 37 Regional network map
Fig. 38 Competitive Dashboard Analysis
Fig. 39 Molecular diagnostics market: Products outlook and key takeaways
Fig. 40 Molecular diagnostics market: Products movement analysis
Fig. 41 Instruments market estimates and forecast, 2018-2030 (USD Million)
Fig. 42 Reagents market estimates and forecast, 2018-2030 (USD Million)
Fig. 43 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 44 Molecular diagnostics market: Test location outlook and key takeaways
Fig. 45 Molecular diagnostics market: Test location movement analysis
Fig. 46 PoC market estimates and forecast, 2018-2030 (USD Million)
Fig. 47 Self-test or over the counter market estimates and forecast, 2018-2030 (USD Million)
Fig. 48 Central laboratories market estimates and forecast, 2018-2030 (USD Million)
Fig. 49 Molecular diagnostics market: Technology outlook and key takeaways
Fig. 50 Molecular diagnostics market: Technology movement analysis
Fig. 51 Polymerase chain reaction (PCR) market estimates and forecast, 2018-2030 (USD Million)
Fig. 52 Nucleic acid extraction and purification market estimates and forecast, 2018-2030 (USD Million)
Fig. 53 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 54 Multiplex PCR market estimates and forecast, 2018-2030 (USD Million)
Fig. 55 Other PCR market estimates and forecast, 2018-2030 (USD Million)
Fig. 56 Instruments PCR market estimates and forecast, 2018-2030 (USD Million)
Fig. 57 Reagents PCR market estimates and forecast, 2018-2030 (USD Million)
Fig. 58 Others PCR market estimates and forecast, 2018-2030 (USD Million)
Fig. 59 In situ hybridization (ISH) market estimates and forecast, 2018-2030 (USD Million)
Fig. 60 Instruments ISH market estimates and forecast, 2018-2030 (USD Million)
Fig. 61 Reagents ISH market estimates and forecast, 2018-2030 (USD Million)
Fig. 62 Others ISH market estimates and forecast, 2018-2030 (USD Million)
Fig. 63 INAAT market estimates and forecast, 2018-2030 (USD Million)
Fig. 64 Instruments INAAT market estimates and forecast, 2018-2030 (USD Million)
Fig. 65 Reagents INAAT market estimates and forecast, 2018-2030 (USD Million)
Fig. 66 Others INAAT market estimates and forecast, 2018-2030 (USD Million)
Fig. 67 Chips and microarrays market estimates and forecast, 2018-2030 (USD Million)
Fig. 68 Instruments chips and microarrays market estimates and forecast, 2018-2030 (USD Million)
Fig. 69 Reagents chips and microarrays market estimates and forecast, 2018-2030 (USD Million)
Fig. 70 Others chips and microarrays market estimates and forecast, 2018-2030 (USD Million)
Fig. 71 Mass spectrometry market estimates and forecast, 2018-2030 (USD Million)
Fig. 72 Instruments mass spectrometry market estimates and forecast, 2018-2030 (USD Million)
Fig. 73 Reagents mass spectrometry market estimates and forecast, 2018-2030 (USD Million)
Fig. 74 Others mass spectrometry market estimates and forecast, 2018-2030 (USD Million)
Fig. 75 Sequencing market estimates and forecast, 2018-2030 (USD Million)
Fig. 76 Instruments sequencing market estimates and forecast, 2018-2030 (USD Million)
Fig. 77 Reagents sequencing market estimates and forecast, 2018-2030 (USD Million)
Fig. 78 Others sequencing market estimates and forecast, 2018-2030 (USD Million)
Fig. 79 Transcription mediated amplification (TMA) market estimates and forecast, 2018-2030 (USD Million)
Fig. 80 Instruments TMA market estimates and forecast, 2018-2030 (USD Million)
Fig. 81 Reagents TMA market estimates and forecast, 2018-2030 (USD Million)
Fig. 82 Others TMA market estimates and forecast, 2018-2030 (USD Million)
Fig. 83 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 84 Instruments others market estimates and forecast, 2018-2030 (USD Million)
Fig. 85 Reagents others market estimates and forecast, 2018-2030 (USD Million)
Fig. 86 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 87 Molecular diagnostics market: Application outlook and key takeaways
Fig. 88 Molecular diagnostics market: Application movement analysis
Fig. 89 Oncology market estimates and forecast, 2018-2030 (USD Million)
Fig. 90 Breast cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 91 Prostate cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 92 Colorectal cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 93 Cervical cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 94 Kidney cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 95 Liver cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 96 Blood cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 97 Lung cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 98 Other cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 99 Pharmacogenomics market estimates and forecast, 2018-2030 (USD Million)
Fig. 100 Infectious diseases market estimates and forecast, 2018-2030 (USD Million)
Fig. 101 MRSA market estimates and forecast, 2018-2030 (USD Million)
Fig. 102 lostridium difficile market estimates and forecast, 2018-2030 (USD Million)
Fig. 103 VRE market estimates and forecast, 2018-2030 (USD Million)
Fig. 104 Carbapenem-resistant bacteria market estimates and forecast, 2018-2030 (USD Million)
Fig. 105 Flu market estimates and forecast, 2018-2030 (USD Million)
Fig. 106 RSV market estimates and forecast, 2018-2030 (USD Million)
Fig. 107 Candida market estimates and forecast, 2018-2030 (USD Million)
Fig. 108 TB and drug-resistant TB market estimates and forecast, 2018-2030 (USD Million)
Fig. 109 Meningitis cancer market estimates and forecast, 2018-2030 (USD Million)
Fig. 110 Gastrointestinal panel testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 111 Chlamydia market estimates and forecast, 2018-2030 (USD Million)
Fig. 112 Gonorrhea market estimates and forecast, 2018-2030 (USD Million)
Fig. 113 HIV market estimates and forecast, 2018-2030 (USD Million)
Fig. 114 Hepatitis C market estimates and forecast, 2018-2030 (USD Million)
Fig. 115 Hepatitis B market estimates and forecast, 2018-2030 (USD Million)
Fig. 116 Other infectious disease market estimates and forecast, 2018-2030 (USD Million)
Fig. 117 Genetic testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 118 Newborn screening market estimates and forecast, 2018-2030 (USD Million)
Fig. 119 Predictive and presymptomatic testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 120 Other genetic testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 121 Neurological diseases market estimates and forecast, 2018-2030 (USD Million)
Fig. 122 Cardiovascular diseases market estimates and forecast, 2018-2030 (USD Million)
Fig. 123 Microbiology market estimates and forecast, 2018-2030 (USD Million)
Fig. 124 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 125 Molecular diagnostics market: Regional outlook and key takeaways
Fig. 126 Molecular diagnostics market: Regional movement analysis
Fig. 127 North America
Fig. 128 North America, SWOT
Fig. 129 North America market estimates and forecast, 2018-2030 (USD Million)
Fig. 130 U.S. key country dynamics
Fig. 131 U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 132 Canada key country dynamics
Fig. 133 Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 134 Europe
Fig. 135 Europe, SWOT
Fig. 136 Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 137 UK key country dynamics
Fig. 138 UK market estimates and forecast, 2018-2030 (USD Million)
Fig. 139 Germany key country dynamics
Fig. 140 Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 141 France key country dynamics
Fig. 142 France market estimates and forecast, 2018-2030 (USD Million)
Fig. 143 Spain key country dynamics
Fig. 144 Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 145 Italy key country dynamics
Fig. 146 Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 147 Belgium key country dynamics
Fig. 148 Belgium market estimates and forecast, 2018-2030 (USD Million)
Fig. 149 Switzerland key country dynamics
Fig. 150 Switzerland market estimates and forecast, 2018-2030 (USD Million)
Fig. 151 Netherlands key country dynamics
Fig. 152 Netherlands market estimates and forecast, 2018-2030 (USD Million)
Fig. 153 Poland key country dynamics
Fig. 154 Poland market estimates and forecast, 2018-2030 (USD Million)
Fig. 155 Austria key country dynamics
Fig. 156 Austria market estimates and forecast, 2018-2030 (USD Million)
Fig. 157 Denmark key country dynamics
Fig. 158 Denmark market estimates and forecast, 2018-2030 (USD Million)
Fig. 159 Sweden key country dynamics
Fig. 160 Sweden market estimates and forecast, 2018-2030 (USD Million)
Fig. 161 Turkey key country dynamics
Fig. 162 Turkey market estimates and forecast, 2018-2030 (USD Million)
Fig. 163 Norway key country dynamics
Fig. 164 Norway market estimates and forecast, 2018-2030 (USD Million)
Fig. 165 Asia-Pacific
Fig. 166 Asia-Pacific, SWOT
Fig. 167 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 168 Japan key country dynamics
Fig. 169 Japan market estimates and forecast, 2018-2030 (USD Million)
Fig. 170 China key country dynamics
Fig. 171 China. market estimates and forecast, 2018-2030 (USD Million)
Fig. 172 India key country dynamics
Fig. 173 India. market estimates and forecast, 2018-2030 (USD Million)
Fig. 174 Australia key country dynamics
Fig. 175 Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 176 New Zealand key country dynamics
Fig. 177 New Zealand market estimates and forecast, 2018-2030 (USD Million)
Fig. 178 Sri Lanka key country dynamics
Fig. 179 Sri Lanka market estimates and forecast, 2018-2030 (USD Million)
Fig. 180 Malaysia key country dynamics
Fig. 181 Malaysia market estimates and forecast, 2018-2030 (USD Million)
Fig. 182 Thailand key country dynamics
Fig. 183 Thailand market estimates and forecast, 2018-2030 (USD Million)
Fig. 184 Vietnam key country dynamics
Fig. 185 Vietnam market estimates and forecast, 2018-2030 (USD Million)
Fig. 186 Singapore key country dynamics
Fig. 187 Singapore market estimates and forecast, 2018-2030 (USD Million)
Fig. 188 South Korea key country dynamics
Fig. 189 South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 190 Latin America
Fig. 191 Latin America, SWOT
Fig. 192 Latin America market estimates and forecast, 2018-2030 (USD Million)
Fig. 193 Brazil key country dynamics
Fig. 194 Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 195 Mexico key country dynamics
Fig. 196 Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 197 Colombia key country dynamics
Fig. 198 Colombia market estimates and forecast, 2018-2030 (USD Million)
Fig. 199 Chile key country dynamics
Fig. 200 Chile market estimates and forecast, 2018-2030 (USD Million)
Fig. 201 Peru key country dynamics
Fig. 202 Peru market estimates and forecast, 2018-2030 (USD Million)
Fig. 203 Argentina key country dynamics
Fig. 204 Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 205 Middle East & Africa
Fig. 206 Middle East & Africa, SWOT
Fig. 207 Middle East & Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 208 South Africa key country dynamics
Fig. 209 South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 210 Saudi Arabia key country dynamics
Fig. 211 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 212 Jordan key country dynamics
Fig. 213 Jordan market estimates and forecast, 2018-2030 (USD Million)
Fig. 214 United Arab Emirates key country dynamics
Fig. 215 United Arab Emirates market estimates and forecast, 2018-2030 (USD Million)
Fig. 216 Qatar key country dynamics
Fig. 217 Qatar market estimates and forecast, 2018-2030 (USD Million)
Fig. 218 Kuwait key country dynamics
Fig. 219 Kuwait market estimates and forecast, 2018-2030 (USD Million)
Fig. 220 Egypt key country dynamics
Fig. 221 Egypt market estimates and forecast, 2018-2030 (USD Million)
Fig. 222 Strategy Framework
Fig. 223 Participant categorization

Companies Mentioned

  • QIAGEN
  • BD
  • bioMérieux SA
  • F. Hoffmann-La Roche, Ltd.
  • Hologic, Inc. (Gen Probe)
  • Abbott
  • Agilent Technologies, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Illumina, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Molecular Diagnostics - Global Strategic Business Report - Product Image

Molecular Diagnostics - Global Strategic Business Report

  • Report
  • 880 Pages
  • Global
From
U.S. Molecular Diagnostics Market Size, Share & Trends Analysis Report By Disease (Healthcare-associated Infections, Respiratory), By End-use (Hospital Core Laboratory, Decentralized Test Sites), And Segment Forecasts, 2023 - 2030 - Product Image

U.S. Molecular Diagnostics Market Size, Share & Trends Analysis Report By Disease (Healthcare-associated Infections, Respiratory), By End-use (Hospital Core Laboratory, Decentralized Test Sites), And Segment Forecasts, 2023 - 2030

  • Report
  • 100 Pages
  • United States
From
North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030 - Product Image

North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • North America
From
Molecular Diagnostics - Product Image

Molecular Diagnostics

  • Newsletter
  • 100 Pages
  • Global
Global Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report by Type (Breast Cancer, Lung Cancer), Product (Instruments, Reagents), Technology (PCR, Sequencing), Region, and Segment Forecasts, 2023-2030 - Product Image

Global Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report by Type (Breast Cancer, Lung Cancer), Product (Instruments, Reagents), Technology (PCR, Sequencing), Region, and Segment Forecasts, 2023-2030

  • Report
  • 139 Pages
  • Global
From

About the Molecular Diagnostics Market

Molecular Diagnostics is a type of medical testing that uses molecular biology techniques to detect and diagnose diseases. It is used to identify genetic mutations, diagnose infectious diseases, and detect cancer. Molecular Diagnostics can also be used to monitor the effectiveness of treatments. Molecular Diagnostics is used in a variety of settings, including hospitals, laboratories, and research facilities. It is used to diagnose a wide range of conditions, including cancer, infectious diseases, genetic disorders, and inherited diseases. Molecular Diagnostics can also be used to detect the presence of certain viruses and bacteria. Some of the companies in the Molecular Diagnostics market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Cepheid, and Qiagen. These companies provide a range of products and services, including diagnostic tests, reagents, and instruments. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.